Sandan, I really don't mind questions or varying points of view at all. But some of the questions just can't be answered right now. I've asked Mr. Schneiderman a few questions about RapiMeds and his reply was, "I can't reply at this time news will follow". I'm find with that. I let the man do his job. As to varying points of view, I welcome it. And, being a proud member of the CORE, I do allow a lot of latitude. However, when people get nasty and start tearing down a stock I believe in and individuals I respect, they will hear back from me. I have been playing the penny stocks now for near three years and can say I have done quite well. Oh, I've also lost on a few real losers as well. But, I picked SCRC to be a winner and I know it will be. I've been in the pharma industry for 37 years and I've seen company's business plans change mid stream on several occasions, just like we saw with compounding and SCRC. Mr. Schneiderman's decision to explore and develop compounding as a revenue steam has been brilliant. And I know RapiMeds are still alive and well, it's just taking longer to develop than we all thought. All the revenue streams he eluded to on his interview will soon pay off and we the investors will be the beneficiaries of this success.
Sandan, I really don't mind questions or varying points of
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
MIT45 Takes a Stand Against Synthetic Kratom Practices
MIT45's Firm Stance on Kratom Safety MIT45, a leading name in the kratom market, stands firmly against the irresponsible and hazardous practice of producing synthetic 7-hydroxymitragynine (7-OH). This commitment to consumer protection is especially important as products claiming to contain kratom often do not meet safety standards and could threaten public health. By...
Continue Reading
Canso Credit Income Fund Announces Special Distributions This Year
Canso Credit Income Fund's Special Distributions Explained Lysander Funds Limited is excited to share important updates regarding the Canso Credit Income Fund (TSX: PBY). This announcement pertains to the special distributions being issued for various classes of units within the Fund for the tax year ending 2024. Understanding these distributions is vital for both...
Continue Reading
Blue Cross and Blue Shield of Texas Expands Community Support with Grants
Blue Cross and Blue Shield of Texas Awards Community Grants Blue Cross and Blue Shield of Texas (BCBSTX) has announced an impressive investment of $2 million in community-based grants. This funding will go to 84 organizations across the state, all focused on enhancing accessibility to health services and tackling social determinants that significantly impact the...
Continue Reading
Dr. Soroush Baghdadi Enhances Pediatric Care at LuskinOIC
Welcoming Dr. Soroush Baghdadi to Luskin Orthopaedic Institute The Luskin Orthopaedic Institute for Children takes great pride in announcing the addition of Dr. Soroush Baghdadi to its distinguished team of pediatric orthopaedic specialists. With an impressive background enriched by global experience and a passion for pediatric care, Dr. Baghdadi brings a promising vision...
Continue Reading
Fractyl Health to Share Q3 Results and Business Insights Soon
Fractyl Health to Discuss Upcoming Financial Insights In Burlington, Massachusetts, Fractyl Health, Inc. (Nasdaq: GUTS) is preparing to unveil its financial results for the third quarter of 2025 along with business updates. This event is scheduled for a Wednesday at 4:30 PM ET, where key insights into the company’s progress will be shared. Accessing the Live Event...
Continue Reading